| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5587957 | Journal of Clinical & Translational Endocrinology | 2017 | 37 Pages |
Abstract
Here, we report two noteworthy genes, ACSBG1 and MAST1; the aberrant promoter methylation/demethylation of these genes might be involved in their silencing/expression in malignant PCC/PGL. Further investigations are necessary to determine the role of ACSBG1 and/or MAST1 expression in malignant transformation and to establish pathological markers that can evaluate the malignant potential of PCC/PGL.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Toshihiro Oishi, Kazumi Iino, Yuta Okawa, Keisuke Kakizawa, Shoko Matsunari, Miho Yamashita, Terumi Taniguchi, Masato Maekawa, Takafumi Suda, Yutaka Oki,